We assign a fundamental rating of 3 out of 10 to ASND. ASND was compared to 524 industry peers in the Biotechnology industry. ASND has a bad profitability rating. Also its financial health evaluation is rather negative. ASND is valued quite expensively, but it does show have an excellent growth rating.

Quickly go to:

1. Profitability

2. Health

3. Growth

4. Valuation

5. Dividend

1. Profitability

1.1 Basic Checks

ASND had negative earnings in the past year.
ASND had a negative operating cash flow in the past year.
In the past 5 years ASND always reported negative net income.
In the past 5 years ASND always reported negative operating cash flow.

1.2 Ratios

ASND's Return On Assets of -20.17% is fine compared to the rest of the industry. ASND outperforms 76.53% of its industry peers.

		Industry Rank	Sector Rank
ROA	-20.17%
ROE	N/A
ROIC	N/A

ROA(3y)-47.96%

ROA(5y)-44.4%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

ASND has a better Gross Margin (86.80%) than 89.31% of its industry peers.
ASND's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for ASND so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	86.8%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y17.06%

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

ASND does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ASND has been increased compared to 1 year ago.
The number of shares outstanding for ASND has been increased compared to 5 years ago.
Compared to 1 year ago, ASND has an improved debt to assets ratio.

2.2 Solvency

ASND has an Altman-Z score of 2.11. This is not the best score and indicates that ASND is in the grey zone with still only limited risk for bankruptcy at the moment.
ASND has a better Altman-Z score (2.11) than 67.18% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF	N/A
Altman-Z	2.11

ROIC/WACCN/A

WACC7.05%

2.3 Liquidity

ASND has a Current Ratio of 1.03. This is a normal value and indicates that ASND is financially healthy and should not expect problems in meeting its short term obligations.
ASND's Current ratio of 1.03 is on the low side compared to the rest of the industry. ASND is outperformed by 85.50% of its industry peers.
A Quick Ratio of 0.73 indicates that ASND may have some problems paying its short term obligations.
The Quick ratio of ASND (0.73) is worse than 87.79% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	1.03
Quick Ratio	0.73

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

ASND shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 48.33%, which is quite impressive.
Looking at the last year, ASND shows a very strong growth in Revenue. The Revenue has grown by 97.46%.
ASND shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 93.57% yearly.

EPS 1Y (TTM)48.33%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%41.86%

Revenue 1Y (TTM)97.46%

Revenue growth 3Y260.22%

Revenue growth 5Y93.57%

Sales Q2Q%269.4%

3.2 Future

The Earnings Per Share is expected to grow by 39.49% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 57.15% on average over the next years. This is a very strong growth

EPS Next Y48.58%

EPS Next 2Y58.62%

EPS Next 3Y50.07%

EPS Next 5Y39.49%

Revenue Next Year128.4%

Revenue Next 2Y105.07%

Revenue Next 3Y82.16%

Revenue Next 5Y57.15%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ASND. In the last year negative earnings were reported.
Based on the Price/Forward Earnings ratio of 55.33, the valuation of ASND can be described as expensive.
Based on the Price/Forward Earnings ratio, ASND is valued cheaper than 89.69% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 25.57, ASND is valued quite expensively.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	55.33

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

ASND's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as ASND's earnings are expected to grow with 50.07% in the coming years.